MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Hemichorea secondary to Middle Cerebral Artery (MCA) Stenosis without evidence of ischemic stroke in the basal ganglia

    M. Bruno (Honolulu, USA)

    Objective: To describe two patients who presented with hemichorea from isolated MCA stenosis without evidence of basal ganglia stroke. Background: Hyperkinetic movement disorders can occur…
  • 2022 International Congress

    Response of freezing, posture and voice to increasing levodopa doses in Parkinson’s disease

    G. Imbalzano, D. Rinaldi, G. Calandra Buonaura, M. Contin, F. Amato, G. Giannini, L. Sambati, C. Ledda, A. Romagnolo, G. Olmo, P. Cortelli, M. Zibetti, C. Artusi, L. Lopiano (Torino, Italy)

    Objective: To analyze the resistance to high levodopa doses of FoG, posture, speech, and gait features in PD patients during a daily-ON therapeutic condition. Background:…
  • 2022 International Congress

    Theta-burst Cycling for Deep Brain Stimulation

    J. Maclean, J. Olaya, M. Liker, T. Sanger (Orange, USA)

    Objective: To test the clinical efficacy of rapid-cycling deep brain stimulation (DBS) in children and young adults with dystonia. Background: Cycling of DBS for variable…
  • 2022 International Congress

    Cognitive-motor tests markedly increase the diagnostic rate of “On-meds” freezing of gait in Parkinson’s disease during clinical visits

    Z. Pei (Guangzhou, China)

    Objective: To develop a testing and recording system that can reliably increase the rate of diagnosing freezing of gait (FOG) in patients living with Parkinson’s…
  • 2022 International Congress

    Subcortical Atrophy and Fall Risk in Parkinson’s Disease

    S. Aggarwal, J. Ma, M. Salgado, M. Hamed (Chicago, USA)

    Objective: To evaluate the relationship between various measures of subcortical atrophy with fall risk in PD. Background: Falls occur in nearly 70% of people with…
  • 2022 International Congress

    CAREGIVERS BURDEN IN CARING FOR PERSONS WITH PARKINSON’S DISEASE: A SURVEY FROM A TEACHING HOSPITAL IN GHANA

    M. Agoriwo, D. Markwei, E. Womorde (Ho, Ghana)

    Objective: To determine the burden of caregivers in caring for persons with Parkinson’s disease (PD) and establish the relationship between the burden of care and…
  • 2022 International Congress

    Utility of Seed Amplification Assay for Detecting α-synuclein in Formalin-Fixed Paraffin Embedded Skin Samples in Parkinson’s Disease

    S. Mosovsky, M. Hepker, A. Kanthasamy, S. Pritzkow, M. Pinho, C. Adler, T. Beach, T. Foroud, G. Serrano, J. Eberling, L. Oliveira, S. Appel, B. Mollenhauer, L. Chahine (Pittsburgh, USA)

    Objective: To determine the sensitivity for Parkinson’s disease (PD) diagnosis of seed amplification assay (SAA) for α-synuclein (α-syn) in formalin-fixed paraffin-embedded (FFPE) skin specimens and…
  • 2022 International Congress

    Preclinical Characterization of Suvecaltamide for Essential Tremor

    E. Brigham, N. Shanks, S. Markova, L. Tan, J. Kramer, D. Huffman, M. Lee (Palo Alto, USA)

    Objective: To characterize the in vitro T-type calcium (CaV3) channel target pharmacology and in vivo anti-tremor profile of suvecaltamide (JZP385, CX-8998). Background: CaV3 channels, a…
  • 2022 International Congress

    The level of glial neurotrophic factor in blood plasma depending on the stage of Parkinson’s disease

    R. Matmurodov, M. Muminov, A. Abduqodirov, K. Khalimova (Tashkent, Uzbekistan)

    Objective: To study the level of glial neurotrophic disease in blood plasma in patients with Parkinson's disease (PD) depending on the stage Background: Parkinson's disease…
  • 2022 International Congress

    Investigation of Modifiers of β-Glucocerebrosidase in Cell Models of Parkinson’s Disease

    A. Wernick, J. Evans, G. Virdi, M. Choi, D. Athauda, Z. Zanjani Shadman, H. Plun-Favreau, S. Wray, S. Gandhi (London, United Kingdom)

    Objective: We firstly aim to identify modifiers of β-glucocerebrosidase (GCase) activity and expression in Parkinson’s disease (PD) relevant cell models. We secondly aim to ascertain…
  • « Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley